Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins

Nat Commun. 2019 Jan 3;10(1):45. doi: 10.1038/s41467-018-07845-z.

Abstract

Programmable nucleases have enabled rapid and accessible genome engineering in eukaryotic cells and living organisms. However, their delivery into target cells can be technically challenging when working with primary cells or in vivo. Here, we use engineered murine leukemia virus-like particles loaded with Cas9-sgRNA ribonucleoproteins (Nanoblades) to induce efficient genome-editing in cell lines and primary cells including human induced pluripotent stem cells, human hematopoietic stem cells and mouse bone-marrow cells. Transgene-free Nanoblades are also capable of in vivo genome-editing in mouse embryos and in the liver of injected mice. Nanoblades can be complexed with donor DNA for "all-in-one" homology-directed repair or programmed with modified Cas9 variants to mediate transcriptional up-regulation of target genes. Nanoblades preparation process is simple, relatively inexpensive and can be easily implemented in any laboratory equipped for cellular biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CRISPR-Associated Protein 9 / genetics*
  • Cell Line, Tumor
  • DNA Repair / genetics
  • Embryo, Mammalian
  • Fibroblasts
  • Gene Editing / economics
  • Gene Editing / methods*
  • Genetic Vectors / genetics*
  • Genome / genetics
  • HEK293 Cells
  • Hematopoietic Stem Cells
  • Humans
  • Induced Pluripotent Stem Cells
  • Leukemia Virus, Murine / genetics
  • Macrophages
  • Mice
  • Mice, Inbred C57BL
  • Primary Cell Culture
  • RNA, Guide / genetics*
  • Ribonucleoproteins / genetics*
  • Transcriptional Activation / genetics

Substances

  • RNA, Guide
  • Ribonucleoproteins
  • CRISPR-Associated Protein 9